STAT6 and central nervous system cancer: Using DNA methyltransferase inhibitors, such as five-azacitidine and decitabine, to restore STAT6 expression in STAT6-silenced gliomas can increase tumor cell death, which would provide a new treatment (Park et al., 2019).